VisionClearBlue Eye Clinic Business Plan — Industry & Market Analysis

VisionClearBlue operates in a market defined by a rare combination: very large, structurally growing demand and a severe, persistent shortage of supply. South Africa carries a heavy and rising burden of eye disease, cataract, diabetic retinopathy, glaucoma and refractive error, yet has among the lowest ophthalmologist densities of any middle-income country, concentrated in a handful of metros. This section sets out the demand fundamentals, the supply constraint that defines the opportunity, and the market’s structure.

Demand — large, growing and unmet

The demand for eye care is substantial and compounding. Cataract is the leading cause of avoidable blindness, and South Africa has never met the World Health Organization Vision 2020 target of 2,000 cataract surgeries per million population per year, actual rates have hovered around 850–950 per million, leaving a large and growing backlog with public-sector waiting lists of up to eighteen months. Rising diabetes prevalence is driving a parallel epidemic of diabetic retinopathy, an ageing population is increasing cataract and glaucoma incidence, and refractive error remains widely under-corrected. The demand is not in question; the capacity to meet it is.

Figure 12. *Drivers of South African eye-care demand*

Supply — the defining constraint

South Africa has only around 324 to 400 ophthalmologists in total, roughly 6 to 7 per million people, against about 25 per million in comparable middle-income markets and 83 per million in the United States. They are heavily concentrated in Gauteng, the Western Cape and KwaZulu-Natal, leaving several provinces critically under-served. Research consistently finds that cataract-surgery output is determined primarily by surgeon availability rather than demand or facilities. This supply constraint is simultaneously the market opportunity, unmet demand a private network can serve, and the central risk, since VisionClearBlue must itself secure the scarce specialists to deliver.

Figure 13. *Ophthalmologists per million population — South Africa versus peers*

Key findingThe opportunity and the risk are two sides of the same shortage

The under-supply of ophthalmologists is exactly why a well-run private eye-care network is needed, and exactly why it is hard to build. The vast unmet demand (backlogs, missed WHO targets, a rising diabetic-eye-disease burden) underwrites strong volumes for any operator that can actually deliver care. But the same shortage means the operator must win the competition for scarce specialists and lift each one’s productivity through technology and task-sharing. Prospective investors should underwrite the Group’s specialist-recruitment and throughput plan as rigorously as its financial model, the demand will be there; the question is whether the clinics can be staffed and run to meet it.

Procedure economics and pricing

Private eye-care pricing is anchored by medical-aid tariffs for reimbursed procedures and by market rates for elective and private-pay services. The indicative ranges below frame the revenue-per-procedure economics that underpin the model, with high-value surgery balanced by higher-volume consultations and optical.

Service	Indicative value	Payer
Cataract surgery (per eye)	~R20,000–35,000	Medical aid / private
Laser vision correction (per eye)	~R15,000–25,000	Largely private-pay
Specialist consultation	~R1,000–2,000	Medical aid / private
Optical (spectacles/lenses)	~R1,500–4,000	Medical aid / cash
Diabetic / occupational screening	Contracted	Corporate / government

Market sizing — TAM, SAM, SOM

Layer	Definition	Indicative scale
TAM	SA private eye-care & optical spend	~R25bn per year
SAM	Medical-aid & private-pay surgical + optical	~R9bn per year
SOM	VisionClearBlue at maturity	~R1.2bn per year

The private eye-care and optical market is large and growing: the ophthalmic-devices market alone is worth some US$250 million a year and growing at over 4%, a proxy for the broader clinical and optical spend that runs to tens of billions of rand. A single mature nine-clinic network capturing ~R1.2 billion represents a modest share of a large, under-served market, leaving substantial headroom for the satellite and regional expansion in the longer-term vision.

Figure 15. *A structurally growing, under-served market*

The sizing is deliberately conservative. The total private eye-care and optical market runs to tens of billions of rand a year and is growing steadily; the serviceable segment of medical-aid and private-pay surgical and optical demand is on the order of R9 billion; and a mature nine-clinic network capturing ~R1.2 billion represents a small share of a large, under-served market. That headroom, together with the unmet public-sector backlog, is what underpins both the base-case ramp and the longer-term satellite and regional expansion opportunity.